IB 1744-HCl
Product Detail
Khoom cim npe
Pob Loj | Muaj | Nqe (USD) |
25mg ib | Hauv Tshuag | 210 |
100 mg | Hauv Tshuag | 530 |
250 mg | Hauv Tshuag | 900 |
1000 mg | Hauv Tshuag | 1650 |
Lub npe tshuaj:
(R)-6-hydroxy-8-(1-hydroxy-2-((1-(4-methoxyphenyl)-2-methylpropan-2-yl)amino)ethyl)-2H-benzo[b][1,4] oxazin-3(4H)-ib hydrochloride
SMILES Code:
O=C1NC2=CC(O)=CC([C@@H](O)CNC(C)(C)CC3=CC=C(OC)C=C3)=C2OC1.[H]Cl
InChi Code:
InChI = 1S/C21H26N2O5.ClH/c1-21(2,10-13-4-6-15(27-3)7-5-13)22-11-18(25)16-8-14(24) 9-1 7-20(16)28-12-19(26)23-17;/h4-9,18,22,24-25H,10-12H2,1-3H3,(H,23,26);1H/t18 -;/m0./s1
InChi Key:
KCEHVJZZIGJAAW-FERBBOLQSA-N
Lo lus tseem ceeb:
IB-1744, Striverdi, 868049-49-4
Solubility:Soluble hauv H2O
Cia:0 - 4 ° C rau lub sijhawm luv (hnub mus rau lub lis piam), lossis -20 ° C rau lub sijhawm ntev (hli).
Nqe lus piav qhia:
BI 1744, yog ib tug ntev ua yeeb yam beta-adrenoceptor agonist siv raws li ib tug inhalation rau kho cov neeg mob uas muaj kab mob ntsws ntev (COPD), tsim los ntawm Boehringer-Ingelheim.
Target: LAAB